Eline van Overbeeke is the Director of Global Access Strategy & Pricing for Specialty Care at Pfizer, a role they have held since 2023. Previously, Eline served as a Health Economics and Outcomes Research Manager at Pfizer starting in 2020. Their academic journey includes a PhD in Pharmaceutical Sciences from KU Leuven, awarded in 2020, focusing on patient preferences in gene therapies. Eline has been actively engaged in various projects, including serving on the Steering Committee for the PREFER project and as a member of the Technical Advisory Board for Pfizer's Global Patient Preference Studies. They also contributed to the IMI EHDEN project as a WP2 Lead and ExCom Member.
This person is not in any teams
This person is not in any offices